Visiongain Report Provides Critical Market-led Data on the $71bn Indian Pharmaceutical Market
Friday, July 12, 2019
Indian Pharmaceutical Market Forecast 2019-2029
LONDON, July 12, 2019 /PRNewswire/ -- Infectious Disease, Cardiovascular, Gastrointestinal, Respiratory, Pain Relief / Analgesics, Diabetes, Vitamins/ Minerals/ Nutrients, Dermatology, CNS, Gynaecology, Generic, OTC, Patented, Biosimilar, Leading Companies
http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg
The Indian pharmaceuticals market is estimated to have reach $28.8bn in 2018 and is expected to grow at a CAGR of 16.6% in the first half of the forecast period. The market for cardiovascular medication is the fastest growing segment of the Indian pharmaceutical market, followed by the anti-infective segment.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page Visiongain report you will receive 121 charts- all unavailable elsewhere.
The 212-page report provides clear detailed insight into the Indian Pharmaceutical Market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
To request sample pages from this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/indian-pharmaceutical-market-forecast-2019-2029/#download_sampe_div
Report Scope
-- Indian Pharmaceuticals Market forecasts from 2019-2029
-- Revenue forecasts for the leading therapeutic areas in India from 2019-2029: -- Anti-Infectives Therapeutics -- Cardiovascular Therapeutics -- Dermatological Therapeutics -- Diabetes Therapeutics -- Gastrointestinal Therapeutics -- Gynaecology Therapeutics -- CNS Therapeutics -- Pain Relief/Analgesics Therapeutics -- Respiratory Therapeutics -- Vitamins/Minerals/Nutrients Therapeutics -- Other Therapeutics
This report also discusses factors that drive and restrain these submarkets.
-- Revenue forecasts for the leading drug types in India from 2019-2029: -- Generic Drugs -- Over-the-Counter (OTC) Drugs -- Patented Drugs -- Biosimilar Drugs
This report also discusses factors that drive and restrain these submarkets.
-- Profiles and discusses the leading companies in the Indian pharmaceutical market: -- Abbott Healthcare Private Limited (Abbott India) -- Cadila Healthcare Limited -- Cipla Ltd. -- Dr. Reddy's Laboratories Ltd. -- GlaxoSmithKline Pharmaceuticals Limited -- Glenmark Pharmaceuticals Limited -- Intas Pharmaceuticals Limited -- Lupin -- Pfizer Limited -- Sanofi India Limited -- Sun Pharmaceuticals Industries Limited
(Revenues are provided for those companies whose financial information is available on the public domain)
-- Analysis of the drivers and restraints of the Indian Pharmaceutical market -- The report also discusses the Porter's Five Forces Analysis and SWOT Analysis of the Indian Pharmaceuticals Market
-- This report also discusses: -- Indian healthcare system and Indian healthcare expenditure -- Indian pharmaceutical regulatory framework, laws & regulations, market access, regulatory bodies -- Disease prevalence and incidence in India, disease mortality rates in India, top causes of death in India, mortality projections from 2019-2029
-- What this report provides: -- The Indian pharmaceutical market forecasts and analysis from 2019 to 2029 -- Analysis and forecasts for the Indian pharmaceutical submarkets from 2019 to 2029 -- Profiles of the leading companies operating within the Indian pharmaceutical industry -- SWOT analysis and Porter's five forces analysis of the major strengths and weaknesses of the Indian pharmaceutical market together with the opportunities available and the key threats faced
To request a report overview of this report please contact Sara Peerun at sara.peerun@visiongain.com or refer to our website: https://www.visiongain.com/report/indian-pharmaceutical-market-forecast-2019-2029/
Did you know that we also offer a report add-on service? Email sara.peerun@visiongain.com to discuss any customized research needs you may have.
Companies covered in the report include:
Abbott India Able Labs Ajanta Pharma Ltd Akumentis Healthcare Ltd Albert David Ltd Alembic Alkem Almirall Amgen Apex Laboratories Pvt. Ltd Aristo Pharma Ascendis Pharma AstraZeneca Aventis Pharma Limited Bayer Bharat Serums Biocon Ltd Biosintez Blue Cross Laboratories Ltd. Cadila Healthcare Ltd. Caraco Chattem Chemicals, Inc. Cipla Claris Lifesciences Daiichi Sankyo Divis Laboratories Dr. Reddy's Laboratories DUSA Pharma, Inc. Eli Lilly and Company (India) Pvt. Ltd. Emcare Eris Lifesciences Exelan FDC Fourrts (India) Laboratories Pvt, Ltd Franco India GlaxoSmithKline India Glenmark Pharma GSK India Heinz India Helsinn Group Hetero Drugs Ltd Hoechst India Limited Hoechst Marion Roussel Limited Hoechst Pharmaceuticals Private Limited Indoco Indi Pharma Pvt. Ltd. InSite Vision Intas Pharma InvaGen Ipca Laboratories Janssen JB Chemicals JSC Biosintez Lonza Lupin Macleods MannKind Corporation Medley Pharmaceuticals Ltd MedproPhamaceutica (Pty) Ltd Megafine Pharma Merck KGaA Meyer Organics Micro Labs MSD Pharma Natco Novartis India Novo Nordisk Odomzo Pfizer India Pharmalucence Piramal Healthcare Pola Pharma, Inc. Ranbaxy Raptakos, Brett & Co. Ltd Roche Pharma India Sandoz, Novartis Division Sanofi India Seciera Sun Pharmaceuticals Taro Pharmaceutical Industries Ltd. Teva Pharmaceuticals (Pty)Ltd The Himalaya Drug Company Torrent Pharma True North Unichem URL's USV Wallace Pharmaceuticals Win-Medicare Wockhardt Wockhardt Zydus Wellness Ltd
List of Organizations Mentioned in the Report Australia's TGA (Therapeutic Goods Administration) Central Drugs Standard Control Organisation Competition Commission of India (CCI) Dr. M.G.R. Medical University (TNMGRMU) Drug Consultative Committee Drug Controller General of India Medical Council of India MHLW (Ministry of Health, Labour and Welfare) MHRA (Medicines & Healthcare Products Regulatory Agency) Ministry of Chemicals & Fertilisers Ministry of Health and Family Welfare National AIDS Control Organisation (NACO) National Pharmaceutical Pricing Authority Organisation for Economic Co-operation and Development (OECD) State Food and Drug Administrations The Joint United Nations Programme on HIV/AIDS (UNAIDS) US Federal Trade Commission (FTC) World Health Organization (WHO)
To see a report overview please e-mail Sara Peerun on sara.peerun@visiongain.com
Related reports:
Global OTC Pharmaceutical Market Forecast 2018-2028
Generic Drugs Market Forecast 2018-2028
The Global Respiratory Inhalers Market 2018-2028
Top Generic Drug Producers Market Forecast 2019-2029
Global Asthma & COPD Therapies Market 2019-2029
Global Biosimilars and Follow-On Biologics Market 2019-2029
Top 20 Global Respiratory Inhalers Manufacturers 2019
View original content:http://www.prnewswire.com/news-releases/visiongain-report-provides-critical-market-led-data-on-the-71bn-indian-pharmaceutical-market-300881587.html
SOURCE Visiongain
|
|
|
|
|
 |
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
 |
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
 |
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
 |
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
 |
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
 |
Genpact Named a Leader in ISG Provider Lens(TM) 2025 for Insurance GCCs and Agentic AI Services | Jan 22, 2026
|
 |
Marketing Evolution Announces New Investment Led by Insight Partners to Power AI-Ready Marketing Data for the Agentic Era | Jan 22, 2026
|
 |
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
 |
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
|